Why Neogen Chemicals Shaky Earnings Are Just The Beginning Of Its Problems
| VCII Stock | USD 0.0001 0.00 0.00% |
Under 56% of ViviCells International's investor base is looking to short. The analysis of overall sentiment of trading ViviCells International stock suggests that many investors are alarmed at this time. ViviCells International's investing sentiment shows overall attitude of investors towards ViviCells International.
ViviCells | Build AI portfolio with ViviCells Stock |
A lackluster earnings announcement from Neogen Chemicals Limited last week didnt sink the stock price...
Read at simplywall.st
 |
ViviCells International Fundamental Analysis
We analyze ViviCells International's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ViviCells International using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ViviCells International based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Ratio
Current Ratio Comparative Analysis
ViviCells International is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
ViviCells International Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ViviCells International stock to make a market-neutral strategy. Peer analysis of ViviCells International could also be used in its relative valuation, which is a method of valuing ViviCells International by comparing valuation metrics with similar companies.
Peers
ViviCells International Related Equities
| MOLN | Molecular Partners | 3.86 | ||||
| MNMD | Mind Medicine | 3.25 | ||||
| CNTA | Centessa Pharmaceuticals | 1.98 | ||||
| BNTX | BioNTech | 0.39 | ||||
| DAL | Delta Air | 1.20 | ||||
| ICAGY | International Consolidated | 1.49 | ||||
| FLYX | FlyExclusive, | 1.82 | ||||
| DYAI | Dyadic International | 4.76 |
Complementary Tools for ViviCells Stock analysis
When running ViviCells International's price analysis, check to measure ViviCells International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ViviCells International is operating at the current time. Most of ViviCells International's value examination focuses on studying past and present price action to predict the probability of ViviCells International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ViviCells International's price. Additionally, you may evaluate how the addition of ViviCells International to your portfolios can decrease your overall portfolio volatility.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |